A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer - Drug Trials For Money

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05394259

Contacts

Locations

Layout table for location information

United States, Texas
MD Anderson Cancer Center	RECRUITING NOW
Houston, Texas, United States, 77030
Contact: Yang Lu, MD, PHD 713-792-5768 ylu10@mdanderson.org
Principal Investigator: Yang Lu, MD, PHD

Sponsors and Collaborators

M.D. Anderson Cancer Center

Lantheus Medical Imaging

Investigators

Layout table for investigator information

Principal Investigator:	Yang Lu, MD, PHD	M.D. Anderson Cancer Center

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.